Le Lézard
Classified in: Health, Covid-19 virus
Subjects: AVO, CPG

Ontario Hospitals Express Sincere Thanks to Minister Elliott


TORONTO, March 4, 2022 /CNW/ - On behalf of Ontario hospitals, the Ontario Hospital Association (OHA) wishes to thank the Hon. Christine Elliott, Deputy Premier and Minister of Health, for her years of service to the people of Ontario, especially over the last two years as she led the health system through the COVID-19 pandemic.

"Even under the relentless pressure and significant demands of the global pandemic, Minister Elliott demonstrated her dedication and commitment to the people of Ontario," said Sarah Downey, OHA Board Chair. "The hospital sector truly appreciates her efforts in reinforcing the health care system and delivering the support so vitally needed to maintain access to care throughout this challenging time."

While Minister Elliott will not be seeking re-election in June, the OHA appreciates her openness, dedication, and responsiveness to the needs of the hospital sector.

"Throughout her time as MPP and then as Minister, Minister Elliott has always been available to listen to the concerns of the hospital sector and has worked with us to problem-solve whenever possible," said Anthony Dale, President and CEO. "We will always be grateful for her willingness to work with us in the best interest of the people of Ontario."

The OHA and its member hospitals wish Minister Elliott all the best as she pursues her next chapter and extends its thanks and appreciation to her family who supported her and the province during an extremely demanding past couple of years. 

The Ontario Hospital Association (OHA) is the voice of the province's public hospitals. The OHA serves hospitals through advocacy, learning and engagement, labour relations and data and analytics to build a better health system. We do this by conducting evidence-based research, proposing ideas, convening members and partners, and encouraging responsible dialogue about change.

SOURCE Ontario Hospital Association


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: